The present invention relates to compounds of the general formula (I) and their pharmaceutically acceptable salts. (In the general formula (I), R 1 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, a lower cycloalkyl group, aralkyl represents an kilgi or heterocyclic ring, wherein the group is substituted at the ortho, meta and / or para position by one, two, three or four electronic machine or an electron donor; R 2 is A hydrogen atom, a lower alkyl group, an aryl group, an aralkyl group or a heterocyclic group, which group is optionally substituted with one or more halogen atoms; R 3 represents a lower alkyl group, an aryl group, an aralkyl group or a heterocyclic group, which group is optionally substituted at the ortho, meta or para position with 1, 2, 3 or 4 electron withdrawing or electron-donating groups; R 4 is A hydrogen atom, a lower alkyl group or all acidic functional groups; And n is 1 or 2). The compounds of the present invention can be used as medicines for the treatment of diseases mainly related to neurogenic and / or oxidative stress.
展开▼
机译:本发明涉及通式(I)的化合物及其药学上可接受的盐。 (在通式(I)中,R 1 Sub>表示氢原子,低级烷基,低级烯基,低级环烷基,芳烷基表示基尔基或杂环,其中基团为在一个,两个,三个或四个电子机器或一个电子供体的邻位,间位和/或对位取代; R 2 Sub>是氢原子,低级烷基,芳基,芳烷基或杂环基,该基团任选地被一个或多个卤素原子取代; R 3 Sub>表示低级烷基,芳基,芳烷基或杂环基,该基团是任选的在邻,间或对位被1、2、3或4个吸电子或给电子基团取代; R 4 Sub>为氢原子,低级烷基或所有酸性官能团;以及n是1或2)。本发明的化合物可以用作治疗主要与神经原性和/或氧化应激有关的疾病的药物。
展开▼